Danazol therapy in chronic immune thrombocytopenic purpura

A. Flores, Joan Carles, Jordi Juncà, Eugènia Abella
In: European Journal of Haematology · 1990 · vol. 45(2) , pp. 109–110 · doi:10.1111/j.1600-0609.1990.tb00427.x · PMID:2209813 · W2146936108
letter OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the efficacy of danazol therapy for patients diagnosed with chronic immune thrombocytopenic purpura, reporting on treatment outcomes and patient responses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (1)

References (11)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-10T10:19:00.875778+00:00
License: CC0 · commercial use OK